View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Glucarpidase 2000, Methotrexate toxicity
Protocol-ID: 3060 V1.0 (Mini), GLCR2000, Methotrexate toxicityIndication(s)
- Methotrexate toxicity
Links
- A phase I/II trial of high-dose methotrexate (HDMTX) followed by prophylactic glucarpidase in patients with impaired renal function and central nervous system lymphoma (CNSL). [ASCO Abstracts doi]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 03.03.2026